|
|
|
|
|
|
|
|
| |
|
Roche CoaguChek XS Test Strips
Accurate, precise results in one minute, Coaguchek XS is the only system to perform onboard quality control and determine patient results in a single test chamber 1,2,
Neutralizes therapeutic levels of heparin and LMWH1.
|
|
Roche Coaguchek S Test Strips
The Roche CoaguChek S System is very easy to use. In only three easy steps, it gives instant results, simpler PT/INR testing and better patient care.
|
|
ITC ProTime-PRO Meter Promotion
The ProTime Microcoagulation System is a CLIA WAIVED test which performs prothrombin times from fingerstick whole blood, and displays the results as INR and PT seconds in just 4-5 minutes.
Only ProTime runs two levels of quality control with each patient's sample. It is the only PT analyzer that automatically runs quality control with every test.
|
|
ITC Protime Test Strips
Only ProTime runs two levels of quality control with each patient's sample. It is the only PT analyzer that automatically runs quality control with every test.
|
|
Hemosense Inratio Test Strips
The INRatio test strip is made of laminated layers of transparent plastic featuring a sample well where blood is applied and more. A Hemosense INRatio monitor is required to use these strips.
|
|
Roche Coaguchek Controls
|
Click for Coaguchek Strips & Meters
Click for Coaguchek Tests
Coaguchek, Coaguchek S, Coaguchek XS, Coaguchek Test Information
The CoaguChek system offers patients on oral anticoagulant treatment a simple, fast, and convenient way of directly monitoring their INR results. It only requires a virtually
pain-free fingerprick, a drop of capillary blood, and one minute to get the INR result which will help the physician to monitor the success of the therapy. INR monitoring was never so easy!
Point of Care Anticoagulation Management Solutions-Since 1994, Roche Diagnostics has helped healthcare professionals provide quality care to their patients with a prothrombin time (PT/INR) meter they trust. Today, more point-of-care PT/INR tests
are performed with a CoaguCheck system than with all other devices combined. Studies have shown that point-of-care PT/INR testing with CoaguChek systems may enhance the quality of care by allowing
faster dosage adjustments and closer monitoring of patients on Coumadin (warfarin sodium) therapy. Roche offers a variety of solutions for fast, accurate PT/INR testing at the point of care, including
options for Patient Self-Testing.
ITC ProTime Microcoagulation System provides point of care monitoring for patients on anticoagulation therapy in a physician's office, clinic or at home. Studies show that more frequent testing ensures
patients stay within their therapeutic range longer and thus reduces health complications and emergencies.
CLIA waived, On board quality controls, automatically run with each test, no reagents or calibration necessary, no external controls needed, Sensitive Thromboplastin with an ISI=1.0,
Tenderlett Plus incision and sample collection device, Small fingerstick blood sample,results for face to face dosage adjustments, single drop of blood, Available for patient self testing with continued support.
How is it used?
Since the
Prothrombin time (PT) evaluates the ability of blood to clot properly, it can be used to help diagnose bleeding. When used in this instance, it is often used in
conjunction with the PTT to evaluate the function of all coagulation factors. Occasionally, the test may be used to screen patients for any previously undetected bleeding problems prior to surgical procedures.
The International Normalized Ratio (INR) is used to monitor the effectiveness of blood thinning drugs such as warfarin (Coumadin). These anti-coagulant drugs help inhibit the
formation of blood clots. They are prescribed on a long-term basis to patients who have experienced recurrent inappropriate blood clotting. This includes those who have had
heart attacks, strokes, and deep vein thrombosis (DVT). Anti-coagulant therapy may also be given as a preventative measure in patients who have artificial heart valves and
on a short-term basis to patients who have had surgeries, such as knee replacements. The anti-coagulant drugs must be carefully monitored to maintain a balance between
preventing clots and causing excessive bleeding.
When is it ordered?
If you are taking an anti-coagulant drug, your doctor will check your PT/INR regularly to make sure that your prescription is working properly and that your PT/INR is
appropriately prolonged. There is no set frequency for doing the test. Your doctor will order them often enough to make sure that the drug is producing the desired effect -
that it is increasing your clotting time to a therapeutic level without causing excessive bleeding or bruising.
The PT may be ordered when a patient who is not taking anti-coagulant drugs has signs or symptoms of a bleeding disorder, which can range from nosebleeds, bleeding gums,
bruising, heavy menstrual periods, blood in the stool and/or urine to arthritic-type symptoms (damage from bleeding into joints), loss of vision, and chronic anemia.
|
|
|
|
